InnoCare Pharma Ltd
HKEX:9969

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
HKEX:9969
Watchlist
Price: 12.33 HKD -4.71% Market Closed
Market Cap: 21.8B HKD

Intrinsic Value

The intrinsic value of one InnoCare Pharma Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 12.33 HKD, InnoCare Pharma Ltd is hidden .

InnoCare Pharma Ltd Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
InnoCare Pharma Ltd

Intrinsic Value History
Dive into the past to invest in the future

InnoCare Pharma Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether InnoCare Pharma Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about InnoCare Pharma Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is InnoCare Pharma Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for InnoCare Pharma Ltd.

Explain Valuation
Compare InnoCare Pharma Ltd to
Custom
Choose any stock to compare

Fundamental Analysis

Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
Profitability
Score

Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
Solvency
Score
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about InnoCare Pharma Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
InnoCare Pharma Ltd

Balance Sheet Decomposition
InnoCare Pharma Ltd

Efficiency

Free Cash Flow Analysis
InnoCare Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Wall St
Price Targets

Price Targets Summary
InnoCare Pharma Ltd

Wall Street analysts forecast InnoCare Pharma Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for InnoCare Pharma Ltd is 24.11 HKD with a low forecast of 20.94 HKD and a high forecast of 30.28 HKD.

Lowest
Price Target
20.94 HKD
70% Upside
Average
Price Target
24.11 HKD
96% Upside
Highest
Price Target
30.28 HKD
146% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

InnoCare Pharma Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for InnoCare Pharma Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one InnoCare Pharma Ltd stock?

The intrinsic value of one InnoCare Pharma Ltd stock under the Base Case scenario is hidden HKD.

Is InnoCare Pharma Ltd stock undervalued or overvalued?

Compared to the current market price of 12.33 HKD, InnoCare Pharma Ltd is hidden .

Back to Top